tiprankstipranks
Senores Pharmaceuticals Ltd. (IN:SENORES)
:SENORES
India Market
SENORES
Senores Pharmaceuticals Ltd.
RESEARCH TOOLSreports
Want to see IN:SENORES full AI Analyst Report?

Senores Pharmaceuticals Ltd. (SENORES) Income Statement

1 Followers

Senores Pharmaceuticals Ltd. Income Statement

Last quarter (Q2 2025), Senores Pharmaceuticals Ltd.'s total revenue was ₹1.53B, an increase of 55.29% from previous quarter. In Q2, Senores Pharmaceuticals Ltd.'s net income was ₹323.80M. See Senores Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 25
Total Revenue
₹ 3.83B₹ 6.33B
Gross Profit
₹ 14.11M₹ 3.81B
Operating Expenses
₹ 1.20B₹ 2.44B
Depreciation and Amortization
₹ 168.40M₹ 312.50M
EBITDA
₹ 1.08B₹ 2.15B
Operating Income
₹ 728.10M₹ 1.37B
Other Income/Expenses
₹ -22.40M₹ 220.30M
Pretax Income
₹ 705.70M₹ 1.59B
Net Income
₹ 6.85M₹ 1.15B
Per Share Metrics
Basic EPS
₹ 0.19₹ 26.39
Diluted EPS
₹ 0.19₹ 26.39
Weighted Average Shares Outstanding
 36.37M 43.72M
Weighted Average Shares Outstanding (Diluted)
 36.37M 43.72M
Currency in INR

Senores Pharmaceuticals Ltd. Earnings and Revenue History